WikiDoc Resources for Salicin |
Articles |
---|
Most recent articles on Salicin |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Salicin at Clinical Trials.gov Clinical Trials on Salicin at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Salicin
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Directions to Hospitals Treating Salicin Risk calculators and risk factors for Salicin
|
Healthcare Provider Resources |
Causes & Risk Factors for Salicin |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Salicin (C13H18O7) is an alcoholic β-glycoside which contains D-glucose. Salicin is an anti-inflammatory which is produced from all willow barks. Salicin is closely related chemically to aspirin and has a very similar action in the human body. When consumed, it is metabolized to salicylic acid. The systematic (IUPAC) name of the molecule is 2-(Hydroxymethyl)phenyl β-D-glucopyranoside. It has the following classifications and chemical properties: